Stimulation of accumbal GABAB receptors inhibits delta1-and delta2-opioid receptor-mediated dopamine efflux in the nucleus accumbens of freely moving rats

被引:9
|
作者
Watanabe, Yuriko [1 ,4 ]
Aono, Yuri [2 ]
Komiya, Masamichi [1 ]
Waddington, John L. [3 ]
Saigusa, Tadashi [2 ]
机构
[1] Nihon Univ, Sch Dent Matsudo, Dept Oral Surg, 2-870-1 Sakaecho Nishi, Matsudo, Chiba 2718587, Japan
[2] Nihon Univ, Sch Dent Matsudo, Dept Pharmacol, 2-870-1 Sakaecho Nishi, Matsudo, Chiba 2718587, Japan
[3] Royal Coll Surgeons Ireland, Mol & Cellular Therapeut, Dublin 2, Ireland
[4] Nihon Univ, Grad Sch Dent Matsudo, Oral Surg, 2-870-1 Salcaecho Nishi, Matsudo, Chiba 2718587, Japan
基金
爱尔兰科学基金会; 日本学术振兴会;
关键词
GABA(B) receptor; Delta1-opioid receptor; Delta2-opioid receptor; Nucleus accumbens; Dopamine; Microdialysis; OPIOID RECEPTORS; INDUCED INCREASES; RELEASE; MICRODIALYSIS; NEURONS; ACTIVATION; NEOSTRIATUM; DELTORPHIN; GLUTAMATE; SUBTYPES;
D O I
10.1016/j.ejphar.2018.08.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The nucleus accumbens contains delta-opioid receptors that may decrease inhibitory neurotransmission. As GABA(B) receptors inhibit dopamine release, decrease in activation of GABA(B) receptors may be a mediator of delta-opioid receptor-induced accumbal dopamine efflux. If so, accumbal dopamine efflux induced by delta-opioid receptor activation should be suppressed by stimulating GABA(B) receptors. As delta-opioid receptors are further subdivided into delta1- and delta2-opioid receptors, we analysed the effects of the GABA(B) receptor agonist baclofen on delta1- and delta2-opioid receptor-mediated accumbal dopamine efflux in freely moving rats using in vivo microdialysis. Drugs were applied intracerebrally through the dialysis probe. Doses of compounds show total amount administered (mol) during 25-50 min infusions. Baclofen (2.5 and 5.0 nmol), which did not alter basal dopamine levels, inhibited the delta1-opioid receptor agonist DPDPE (5.0 nmol)-induced dopamine efflux. Baclofen (2.5 and 5.0 nmol) also inhibited the delta2-opioid receptor agonist deltorphin II (25.0 nmol)-induced dopamine efflux. A low dose of the GABA(B) receptor antagonist 2-hydroxysaclofen (100.0 pmol), which failed to alter basal accumbal dopamine levels, counteracted the inhibitory effects of baclofen (5.0 nmol) on DPDPE (5.0 nmol)- and deltorphin II (25.0 nmol)-induced dopamine efflux. The present results show that reduction in accumbal GABA(B) receptor-mediated inhibition of accumbal dopaminergic activity facilitates activation of delta1- and delta2-opioid receptor-induced increases in accumbal dopamine efflux. This study suggests that activation of delta1- and delta2-opioid receptors on the cell bodies and/or terminals of accumbal GABAergic interneurons inhibits GABA release and, accordingly, decreases GABA(B) receptor-mediated inhibition of dopaminergic terminals, resulting in enhanced accumbal dopamine efflux.
引用
下载
收藏
页码:88 / 95
页数:8
相关论文
共 50 条
  • [1] Stimulation of accumbal GABAA receptors inhibits delta2-, but not delta1-, opioid receptor-mediated dopamine efflux in the nucleus accumbens of freely moving rats
    Aono, Yuri
    Kiguchi, Yuri
    Watanabe, Yuriko
    Waddington, John L.
    Saigusa, Tadashi
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2017, 815 : 18 - 25
  • [2] Activation of GABAB receptors inhibits δ2 receptor-mediated accumbal dopamine efflux in rats
    Aono, Yuri
    Watanabe, Yuriko
    Kiguchi, Yuri
    Ishikawa, Manabu
    Shibutani, Koh
    Saigusa, Tadashi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2017, 133 (03) : S170 - S170
  • [3] In vivo neurochemical evidence that stimulation of accumbal GABAA and GABAB receptors each reduce acetylcholine efflux without affecting dopamine efflux in the nucleus accumbens of freely moving rats
    Aono, Yuri
    Watanabe, Yuriko
    Ishikawa, Manabu
    Kuboyama, Noboru
    Waddington, John L.
    Saigusa, Tadashi
    SYNAPSE, 2019, 73 (04)
  • [4] Interactions among mu-, delta1- and delta2-opioid receptors promote dopamine release in the nucleus accumbens
    Koshikawa, N
    Hirose, N
    Lee, J
    Cools, AR
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S378 - S378
  • [5] Concomitant activation of α1-receptor subtypes in the nucleus accumbens reduces accumbal dopamine efflux in freely moving rats
    Aono, Yuri
    Saigusa, Tadashi
    Taguchi, Hiroko
    Cools, Alexander. R.
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2013, 121 : 214P - 214P
  • [6] Role of α1 adrenoceptors in the nucleus accumbens in the regulation of accumbal noradrenaline and dopamine efflux in freely moving rats
    Sekino, Reiko
    Saigusa, Tadashi
    Aono, Yuri
    Oi, Yoshiyuki
    Cools, Alexander R.
    Koshikawa, Noriaki
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2011, 115 : 241P - 241P
  • [7] Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens
    Hirose, N
    Murakawa, K
    Takada, K
    Oi, Y
    Suzuki, T
    Nagase, H
    Cools, AR
    Koshikawa, N
    NEUROSCIENCE, 2005, 135 (01) : 213 - 225
  • [8] Role of GABAB receptors in the endomorphin-1-, but not endomorphin-2-, induced dopamine efflux in the nucleus accumbens of freely moving rats
    Saigusa, Tadashi
    Aono, Yuri
    Mizoguchi, Naoko
    Iwakami, Tomoyo
    Takada, Koji
    Oi, Yoshiyuki
    Ueda, Koichiro
    Koshikawa, Noriaki
    Cools, Alexander R.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 581 (03) : 276 - 282
  • [9] In vivo neurochemical evidence that delta1-, delta2-and mu2-opioid receptors, but not mul1opioid receptors, inhibit acetylcholine efflux in the nucleus accumbens of freely moving rats
    Kiguchi, Yuri
    Aono, Yuri
    Watanabe, Yuriko
    Yamamoto-Nemoto, Seiko
    Shimizu, Kunihiko
    Shimizu, Takehiko
    Kosuge, Yasuhiro
    Waddington, John L.
    Ishige, Kumiko
    Ito, Yoshihisa
    Saigusa, Tadashi
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2016, 789 : 402 - 410
  • [10] The α1 adrenoceptor in the nucleus accumbens plays an inhibitory role on accumbal noradrenaline and dopamine efflux in freely moving rats
    Saigusa, Tadashi
    Aono, Yuri
    Cools, A. R.
    Koshikawa, Noriaki
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2012, 118 : 224P - 224P